Journal of Medicinal Chemistry p. 4913 - 4925 (2016)
Update date:2022-07-29
Topics:
Wang, Heng-Yen
Qin, Yajuan
Li, Huiying
Roman, Linda J.
Martásek, Pavel
Poulos, Thomas L.
Silverman, Richard B.
Neuronal nitric oxide synthase (nNOS) is an important therapeutic target for the treatment of various neurodegenerative disorders. A major challenge in the design of nNOS inhibitors focuses on potency in humans and selectivity over other NOS isoforms. Here we report potent and selective human nNOS inhibitors based on the 2-aminopyridine scaffold with a central pyridine linker. Compound 14j, the most promising inhibitor in this study, exhibits excellent potency for rat nNOS (Ki = 16 nM) with 828-fold n/e and 118-fold n/i selectivity with a Ki value of 13 nM against human nNOS with 1761-fold human n/e selectivity. Compound 14j also displayed good metabolic stability in human liver microsomes, low plasma protein binding, and minimal binding to cytochromes P450 (CYPs), although it had little to no Caco-2 permeability.
View Morewebsite:http://www.u-chemo.com
Contact:+86-21-61558312
Address:Dong Fang Road,
Hubei ShiNan Pharmaceutical Chemical co., Ltd.(expird)
Contact:+86-13554447107
Address:Wuhan HongShanOu wu no road 378 future residence building 1 unit 14 layer no. 1401 A
Hebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
HANGZHOU PANYU CHEMICAL CO.,LIMITED
Contact:+86-571-86578491
Address:Rm 605, NO.1870 Binsheng Road,Binjiang Dist, Hangzhou, China
Lanling Hongchuang Flame Retardant Co., Ltd.
Contact:+86-531-68858132
Address:East Huafeichang Road, Cangshan County, Linyi, Shandong, China (Mainland)
Doi:10.1055/s-2001-16773
(2001)Doi:10.1002/chem.201304063
(2014)Doi:10.1039/f19827800347
(1982)Doi:10.1016/S0040-4039(01)84944-3
(1972)Doi:10.1021/ja01609a033
(1955)Doi:10.1016/j.jinorgbio.2010.03.013
(2010)